Transcranial magnetic stimulation for depression

Technol Eval Cent Assess Program Exec Summ. 2011 Jul;26(3):1-4.
No abstract available

MeSH terms

  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / therapeutic use
  • Blue Cross Blue Shield Insurance Plans
  • Depression / drug therapy
  • Depression / therapy*
  • Device Approval
  • Drug Resistance
  • Humans
  • Meta-Analysis as Topic
  • Outcome Assessment, Health Care
  • Psychiatric Status Rating Scales
  • Randomized Controlled Trials as Topic
  • Technology Assessment, Biomedical
  • Transcranial Magnetic Stimulation / adverse effects
  • Transcranial Magnetic Stimulation / methods*
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration

Substances

  • Antidepressive Agents